ubmslateCN-logo-ubm

CN Mobile Logo

Search form

Topics:

Podcasts

Podcasts

In this interview we discuss the GeneFx Colon test (or the ColDx assay), which can helpful identify patients with low- or high-risk stage II colon cancer.

In this interview we discuss new consensus guidelines from ASCO, SSO, and ASTRO that establish 2 mm surgical margins for treating DCIS patients.

In this interview we discuss a recent study that identified genetic mechanisms of immunoresistance to treatment with anti-PD-1 antibodies.

In this interview we discuss the CheckMate 142 trial, which looked at nivolumab and ipilimumab for the treatment of metastatic colorectal cancer.

In this interview we discuss follow-up care and screening for second primary cancers in cancer survivors.

In this interview we discuss the management of late effects from radiotherapy in patients treated for gynecologic cancers.

In this interview we discuss the requirements for the effective implementation of a lung cancer screening program.

Pages

Subscribe to Podcasts on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.